# Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy

> **NCT01379742** · PHASE4 · UNKNOWN · sponsor: **Prostate Cancer Foundation of Chicago** · enrollment: 240 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** RapidStrand seeds for use with 18g needle
- **DEVICE:** ThinStrand

## Key facts

- **NCT ID:** NCT01379742
- **Lead sponsor:** Prostate Cancer Foundation of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-04
- **Primary completion:** 2013-02
- **Final completion:** —
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2013-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01379742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01379742, "Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01379742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*